Abstract Information

The deadline to submit research for a regular abstract, Young Investigator Award abstract and/or late-breaking abstract application was 5 p.m. PDT on July 29, 2021. For more information, see the 2021 Regular and Late-Breaking Abstract Reference Guide or continue scrolling to learn more about specific abstract categories and timelines.

Abstract Categories and Timelines

• Important Abstract Dates

• Regular Abstracts

• Late-Breaking Abstracts

• Young Investigator Award Abstracts

• Reasons to Submit an Abstract to SITC 2021
  
  

Important Abstract Dates

Regular and Late-Breaking

Poster Presentation Dates

SITC is monitoring the COVID-19 situation and plans to announce any decisions in mid-summer. More information about requirements for accepted abstract presentations is forthcoming.

All odd-numbered posters will be presented on Friday, Nov. 12, 2021, while even-numbered posters will be presented on Saturday, Nov. 13, 2021.

Posters will be on display from 7 a.m.–8 p.m., with the presenting authors required to be at their posters during lunch (12:40–2:10 p.m. on Friday, Nov. 12, and 12:30–2 p.m. on Saturday, Nov. 13) and also during the poster reception (7–8:30 p.m. on Friday, Nov. 12, and 7–8:30 p.m. on Friday, Nov. 12).

Regular Abstracts

The time frame to submit your latest research in the cancer immunotherapy field to the 36^th Annual Meeting & Pre-Conference Programs (SITC 2021) for consideration as an oral abstract presentation, rapid oral abstract presentation, and/or poster abstract presentation is April 23, 2021, until 5 p.m. PDT on July 29, 2021.

Late-Breaking Abstracts

Late-Breaking abstract (LBA) submission is solely for abstracts with late-breaking data and not for abstracts submitted “late”. The late-breaking abstract deadline is not intended to be an extension of the general submission deadline.

All LBA application submissions are due by 5 p.m. PDT on July 29, 2021, to be eligible for the LBA submission period. Applications will be reviewed and all submitters will be notified if they qualify to submit a late-breaking abstract during the submission period from Aug. 19, 2021, to 5 p.m. PDT on Aug. 31, 2021. If an application does not qualify for late-breaking abstract submission, the submitter will be notified by Aug. 10, 2021, and will have the opportunity to submit a regular abstract by 5 p.m. PDT on Aug. 13, 2021.

LBAs are considered for, but not limited to, oral abstract presentations during the LBA Sessions from 12:10–12:40 p.m. on Friday, Nov. 12, 2021, and 12–12:30 p.m. on Saturday, Nov. 13, 2021.

Young Investigator Award Abstracts

Regular abstracts with primary and presenting authors that are students, postdoctoral research fellows, clinical fellows, or junior faculty with three or fewer years on staff and are current SITC members, may be eligible to receive a Young Investigator Award. Young Investigator Award abstracts require a letter of recommendation as well as additional information regarding the percentage of contribution by the primary and presenting author.

Those selected for the Presidential Travel Award will be invited to give an oral abstract presentation during the Presidential Session from 2–3:25 p.m. on Saturday, Nov. 13, 2021.

For more information about the Young Investigator Awards, please click here.

Reasons to Submit an Abstract to SITC 2021

• Free submission for members and nonmembers (view important submission dates)

• Young Investigator Awards are offered in conjunction with regular abstract submission

• All accepted abstracts will be published as a supplement in the Journal for ImmunoTherapy of Cancer (JITC), the society’s global, open access, peer-reviewed journal

• Multiple oral presentation opportunities available

• The opportunity to present and discuss your research with luminaries in the immunotherapy field